Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities-Reference-Cited by-同舟云学术

Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities

Published:2017-06 Issue:6 Volume:116 Page:413-423
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chu Chia-Yu,Chen Kuan-Yu,Wen-Cheng Chang John,Wei Yu-Feng,Lee Chih-Hung,Wang Wei-Ming

Funder

TDA

Boehringer Ingelheim International GmbH

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

2. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung;Han;J Clin Oncol,2012

3. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002);Inoue;Ann Oncol,2013

4. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients;Acta Dermato-Venereologica;2024-08-28

2. Pulsed Azithromycin for the Treatment of Dacomitinib Induced Skin Toxicity in Patient with Tetracycline Intolerance – A Case Report;2024-08-26

3. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

4. DERMATOLOGICAL TOXICITY OF CANCER PATIENTS RECEIVING SMALL MOLECULE EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS – A PROSPECTIVE OBSERVATIONAL STUDY;Asian Journal of Pharmaceutical and Clinical Research;2024-01-07

5. Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare cutaneous toxicity;European Journal of Cancer;2024-01